Skip to Main Content

Author Details

Sandra Edwards
The Institute of Cancer Research
1997
62
35
PMIDPaper TitleJournal TitlePublished Year
28753852DESNT: A Poor Prognosis Category of Human Prostate Cancer.Eur Urol Focus2018
29662167Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.Nat Genet2018
28945760Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.PLoS Genet2017
27798103Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status.Hum Mol Genet2016
25730763Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.Nat Genet2015
26018901Corrigendum: analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.Nat Genet2015
21748754Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG.Prostate2012
22712434Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families.BMC Med Genet2012
21952622BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients.Br J Cancer2011
20104229Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer.Br J Cancer2010
20736950Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.Br J Cancer2010
20177423The identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancer.Prostate Cancer Prostatic Dis2010
19040532Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer.BJU Int2009
19767753Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.Nat Genet2009
19127258A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer.Br J Cancer2009
19050691Identification of new genetic risk factors for prostate cancer.Asian J Androl2009
19016689Sexual activity and prostate cancer risk in men diagnosed at a younger age.BJU Int2009
18264097Multiple newly identified loci associated with prostate cancer susceptibility.Nat Genet2008
18577746Multiple loci with different cancer specificities within the 8q24 gene desert.J Natl Cancer Inst2008
18506189Diagnostic radiation procedures and risk of prostate cancer.Br J Cancer2008
18594527Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer.Br J Cancer2008
18708398Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium.Cancer Epidemiol Biomarkers Prev2008
16909110Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells.Oncogene2007
17043636Diversity of TMPRSS2-ERG fusion transcripts in the human prostate.Oncogene2007
16932970Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics.Hum Genet2006
16938365Nuclear overexpression of the E2F3 transcription factor in human lung cancer.Lung Cancer2006
15734964Macrophage scavenger receptor 1 999C>T (R293X) mutation and risk of prostate cancer.Cancer Epidemiol Biomarkers Prev2005
15858122Processing of radical prostatectomy specimens for correlation of data from histopathological, molecular biological, and radiological studies: a new whole organ technique.J Clin Pathol2005
15988677A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics.Am J Hum Genet2005
15583692Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer.Br J Cancer2005
15711606Association between hormonal genetic polymorphisms and early-onset prostate cancer.Prostate Cancer Prostatic Dis2005
14716298Amplification and overexpression of E2F3 in human bladder cancer.Oncogene2004
20233465The clinical genetics of prostate cancer.Hered Cancer Clin Pract2004
15264274Unravelling the genetics of prostate cancer.Am J Med Genet C Semin Med Genet2004
15180597Proteomics and urine analysis: a potential promising new tool in urology.BJU Int2004
15280931ATM polymorphisms as risk factors for prostate cancer development.Br J Cancer2004
15492233A gene expression signature associated with metastatic outcome in human leiomyosarcomas.Cancer Res2004
12474142Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene.Am J Hum Genet2003
14601023Results of a genome-wide linkage analysis in prostate cancer families ascertained through the ACTANE consortium.Prostate2003
12664059Germline mutations in fumarate hydratase (FH) do not predispose to prostate cancer.Prostate Cancer Prostatic Dis2003
12606952Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarrays.Oncogene2003
12592363Molecular classification of synovial sarcomas, leiomyosarcomas and malignant fibrous histiocytomas by gene expression profiling.Br J Cancer2003
12823393Association between leptin receptor gene polymorphisms and early-onset prostate cancer.BJU Int2003
11921288Identification of amplified and expressed genes in breast cancer by comparative hybridization onto microarrays of randomly selected cDNA clones.Genes Chromosomes Cancer2002
12373607HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease.Br J Cancer2002
12496980Association between the GCG polymorphism of the selenium dependent GPX1 gene and the risk of young onset prostate cancer.Prostate Cancer Prostatic Dis2002
12067976Influence of cytokine gene polymorphisms on the development of prostate cancer.Cancer Res2002
11434510Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer.Pharmacogenetics2001
11241844An improved high throughput heteroduplex mutation detection system for screening BRCA2 mutations-fluorescent mutation detection (F-MD).Hum Mutat2001
11720478No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours.Br J Cancer2001
  • 1 - 50 of 62

Recommended Authors

Martina Kluth
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 2012
Number of shared co-authors 2
Mark M Pomerantz
Dana-Farber Cancer Institute
Career Start Year 2007
Number of shared co-authors 30
Christina M??ller-Koop
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 2006
Number of shared co-authors 2
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 7
Mine S Cicek
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 16
Fredrick R Schumacher
Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine
Career Start Year 2003
Number of shared co-authors 44
Christopher E Barbieri
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 5
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Career Start Year 2003
Number of shared co-authors 15
Tarek A Bismar
University of Calgary Cumming School of Medicine, Rockyview General Hospital
Career Start Year 2002
Number of shared co-authors 12
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 5
Cezary Cybulski
International Hereditary Cancer Center, Pomeranian Medical University
Career Start Year 1998
Number of shared co-authors 48
Mette A Peters
Division of Clinical Research, Fred Hutchinson Cancer Research Center
Career Start Year 1997
Number of shared co-authors 6
Phillip G Febbo
Illumina Inc.
Career Start Year 1997
Number of shared co-authors 2
Claudia Hube-Magg
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1997
Number of shared co-authors 2
Deborah Nusskern
Euclid Diagnostics LLC
Career Start Year 1995
Number of shared co-authors 8
John S Witte
Stanford University School of Medicine
Career Start Year 1994
Number of shared co-authors 33
Peter S Nelson
Fred Hutchinson Cancer Center
Career Start Year 1993
Number of shared co-authors 20
Matthew L Freedman
Dana-Farber Cancer Institute
Career Start Year 1993
Number of shared co-authors 39
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 21
Gyorgy Petrovics
Henry Jackson Foundation for the Advancement of Military Medicine (HJF)
Career Start Year 1990
Number of shared co-authors 23
Guido Jenster
Erasmus University Medical Center
Career Start Year 1990
Number of shared co-authors 27
Colin C Collins
University of British Columbia
Career Start Year 1988
Number of shared co-authors 14
Bharati Bapat
Mt Sinai Hospital
Career Start Year 1988
Number of shared co-authors 14
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Career Start Year 1988
Number of shared co-authors 2
Olli Kallioniemi
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 20
Robin J Leach
University of Texas Health San Antonio
Career Start Year 1984
Number of shared co-authors 22
Heather Thorne
Peter MacCallum Cancer Centre
Career Start Year 1982
Number of shared co-authors 14
Elizabeth M Gillanders
National Cancer Institute, National Institutes of Health
Career Start Year 1981
Number of shared co-authors 29
Francesca Demichelis
University of Trento
Career Start Year 1969
Number of shared co-authors 13
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Career Start Year 1959
Number of shared co-authors 40

Collaborators

Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers 49
Douglas F Easton
University of Cambridge
Co-authored papers 37
Colin S Cooper
Norwich Medical School, University of East Anglia
Co-authored papers 25
Zsofia Kote-Jarai
The Institute of Cancer Research
Co-authored papers 22
Jeremy Clark
Norwich Medical School, University of East Anglia
Co-authored papers 16
Cyril Fisher
University Hospitals Birmingham NHS Foundation Trust
Co-authored papers 13
Graham G Giles
Co-authored papers 12
Penny Flohr
The Institute of Cancer Research
Co-authored papers 12
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers 11
William D Foulkes
Segal Cancer Centre, Jewish General Hospital
Co-authored papers 11
Christopher S Foster
The Institute of Cancer Research
Co-authored papers 11
Alan Thompson
The Royal Marsden NHS Foundation Trust
Co-authored papers 10
Daniel Leongamornlert
Oncogenetics Team The Institute of Cancer Research London UK.
Co-authored papers 9
Chris Ogden
The Royal Marsden Hospital NHS Foundation Trust
Co-authored papers 8
Freddie C Hamdy
University of Oxford
Co-authored papers 8
Janet L Stanford
Fred Hutchinson Cancer Research Center
Co-authored papers 7
Christopher J Woodhouse
Royal Marsden NHS Foundation Trust
Co-authored papers 7
Elaine A Ostrander
National Cancer Institute
Co-authored papers 7
Sue Merson
Institute of Cancer Research
Co-authored papers 7
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Co-authored papers 7
Johanna Schleutker
Institute of Biomedicine, University of Turku
Co-authored papers 7
Nening Dennis
Institute of Cancer Research
Co-authored papers 7
Daniel M Berney
Barts Cancer Institute, Queen Mary University of London
Co-authored papers 7
Shannon K McDonnell
Mayo Clinic
Co-authored papers 6
William B Isaacs
The Brady Urological Institute, The Johns Hopkins School of Medicine
Co-authored papers 6
Stephen N Thibodeau
Mayo Clinic
Co-authored papers 6
Michael R Stratton
Wellcome Sanger Institute
Co-authored papers 6
Daniel J Schaid
Mayo Clinic
Co-authored papers 6
Cathy Corbishley
The Institute of Cancer Research
Co-authored papers 6
Alice S Whittemore
Co-authored papers 5
Release 1.2